President Joe Biden on Wednesday (April 3) touted his administration’s and Sen. Bernie Sanders’ (I-VT) success in pressuring three of four of the nation’s top inhaler manufacturers to cap out-of-pocket costs for patients at no more than $35 a month, saying the administration will look for more ways to get drug makers, who are already backed in a corner due to Medicare drug negotiations, to cut their prices. Biden spotlighted the work of Sanders, who heads the Senate health committee,...